Liraglutide causes large and rapid epicardial fat reduction

Iacobellis, Gianluca, Mohseni, Mahshid, Bianco, Suzy D., Banga, Pritisheel K.·2017·Obesity
DOI 10.1002/oby.21718

Cited by (251)

Items 201–251 of 251

  1. Liraglutide effect on epicardial fat: Missing the forest for the trees
    Andres Julian Munoz, Keisha Bonhomme, Cristina Lara‐Castro · 2017 · Obesity
  2. Response to “Liraglutide effect on epicardial fat: Missing the forest for the trees”
    Gianluca Iacobellis · 2017 · Obesity
  3. Letter to the Editor: “GLP-1 Receptor Expression Within the Human Heart”
    Gianluca Iacobellis · 2018 · Endocrinology
  4. Epicardial Adipose Tissue as a New Target of Therapeutic Interventions
    М. A. Druzhilov, Т. Yu. Kuznetsova · 2020 · Rational Pharmacotherapy in Cardiology
  5. Epicardial adipose tissue in diabetic myocardial disorder: Role of echocardiography
    Ana Đuzel Čokljat, Petra Grubić Rotkvić, Damir Čokljat, Jerko Ferri-Certić, Zdravko Babić · 2025 · World Journal of Diabetes
  6. Research on epicardial adipose tissue as a metabolic therapeutic target in AF: focus on GLP-1 receptor agonists
    Ling Liu, Jie Li Lu · 2026 · Frontiers in Cardiovascular Medicine
  7. Deep learning-derived pericardial adipose tissue by electrocardiogram-gated cardiac computed tomography predicts cardiovascular events beyond coronary calcium score
    Zahra Esmaeili, José R. Medina‐Inojosa, Elham Mahmoudi, Laura M. Ortega-Aviles, Betsy J. Medina‐Inojosa, Bradley James Erickson, Francisco Alejandro López-Jiménez · 2026 · American Journal of Preventive Cardiology
  8. Acute Contractile Effects of Glucagon-like-Peptide-1 Receptor Agonists in the Human Heart
    Joachim Neumann, Uwe Kirchhefer, Britt Hofmann, Ulrich Gergs · 2026 · Pharmaceutics
  9. The Emerging Role of Glucagon-like Peptide 1 (GLP-1)-Based Medications in the Treatment of Heart Failure, with a Focus on Heart Failure with Preserved or Mildly Reduced Ejection Fraction
    Rachel Su Min Lee, Jas‐mine Seah, Sara Baqar, Piyush Srivastava, Eylem Levelt, Angeline S. Leet, Andrew I. MacIsaac, Elif Ilhan Ekinci, Richard J. MacIsaac · 2026 · Medicina
  10. The cardiometabolic triad: obesity, sleep-disordered breathing, and epicardial adipose tissue
    Fulvio Cacciapuoti, Gerardo Carpinella, Francesca Sessa, Massimo Liguori, Flavia Casolaro, Massimo Russo, Nicola Verde, Ciro Mauro · 2026 · Minerva Cardiology and Angiology
  11. Incretin analogues as cardiovascular agents: a state-of-the-art review
    Diego Araiza Garaygordobil, Jorge E. Rico-Fontalvo, Betsabe Hernández-Balbuena, Mónica Vinay, Mauricio Gonzalez-Arias · 2026 · Frontiers in Endocrinology
  12. Targeting the Epicardial Adipose Tissue
    Gianluca Iacobellis · 2020 · Contemporary cardiology
  13. Liraglutide Nano-Preparation on Perioperative Neurocognitive Dysfunction in Aged Mice
    Jiejie Zhang, Jie Song, Tianyu Gu, Jianping Yang, Xuejiao Cai, Mengmeng Cai, Jiafeng Sun · 2022 · Cellular and Molecular Biology
  14. Weight Loss Effects of Glucagon-Like Peptide-One Receptor Analog Treatment in a Severely Obese Patient During Hospital Admission
    Yaiseli Figueredo, Claudia Cottone, Tanira Ferreira, Jesus Gonzalez, Gianluca Iacobellis · 2023 · Cureus
  15. Glucagon-like peptide-1 receptor agonists: role in the prevention and treatment of diabetes-related cardiovascular complications
    Anniek Frederike Lubberding, Jens Juul Holst, Sten Madsbad · 2023 · Elsevier eBooks
  16. Reducing Cardiac Steatosis: Interventions to Improve Diastolic Function: A Narrative Review
    Kiyan Heshmat‐Ghahdarijani, Roya Modaresi, Sobhan Pourmasjedi, Setayesh Sotoudehnia Korani, Ali Rezazadeh Roudkoli, Razieh Ziaei, Armita Farid, Mehrnaz Salehi, Afshin Heidari, Sina Neshat · 2023 · Current Problems in Cardiology
  17. Inflammation and Cardiovascular Outcomes
    Priyanka Satish, Anandita Agarwala · 2024 · Contemporary cardiology
  18. Obesity Medications Beyond Glucose Control and Weight Reduction: Updates on the Expanding Benefits, Clinical Challenges, and Future Directions
    Spyridon Ntelis, Brian S. Wojeck · 2025 · Current Hypertension Reports
  19. Clinical aspects of epicardial fat deposition
    Markéta Sovová · 2020 · Vnitřní lékařství
  20. Role of Epicardial Adipose Tissue in the Maintenance of Atrial Fibrillation
    Yasuo Okumura · 2019 · Journal of Nihon University Medical Association
  21. Transcriptomic and Proteomic Analysis of the Epicardial Adipose Tissue
    Vladimir Camarena, David Sant, Tyler C. Huff, Gaofeng Wang · 2020 · Contemporary cardiology
  22. Fat depot of the heart: contribution to the development of cardiovascular diseases, visualization methods and the possibilities of it’s correction
    Ekaterina S. Bratilova, V. A. Kachnov, Vadim Vitalyevich Tyrenko, I. S. Zheleznyak, Д. В. Черкашин, С. В. Кушнарев, A.D. Sobolev · 2020 · Bulletin of the Russian Military Medical Academy
  23. Drug-induced metabolic alterations in adipose tissue - with an emphasis in epicardial adipose tissue
    Aryane Cruz Oliveira Pinho, Ana Burgeiro, Maria J. Pereira, Eugénia Carvalho · 2022 · Anais da Academia Brasileira de Ciências
  24. 心外膜脂肪と心疾患
    佐田 政隆, 田中 君枝 · 2019 · Journal of JCS Cardiologists
  25. Koroner arter hastalığında epikardiyal yağ doku indeksinin araştırılması
    Mehmet ARSLAN, Ercan Akşıt, Hasan Hüseyin Bozkurt, Başak Korkmazer, Erkan Melih Şahi̇n · 2022 · Troia Medical Journal
  26. Tejido adiposo epicárdico como predictor de enfermedad coronaria. ¿Un nuevo parámetro para la estratificación del riesgo cardiovascular?
    Victoria Creta, Claudio Cesar Higa, Walter M. Masson · 2022 · Revista Argentina de Cardiología
  27. Epicardial Adipose Tissue as Predictor of Coronary Artery Disease. A New Parameter to Stratify Cardiovascular Risk?
    Victoria Creta, Claudio Cesar Higa, Walter M. Masson · 2022 · Revista Argentina de Cardiología
  28. Comparative evaluation new glucagon-like peptide 1 receptor agonist semaglutide and sodium-glucose cotransporter-2 inhibitors empagliflozin on left ventricular diastolic function in patients with arterial hypertension, obesity and type 2 diabetes mellitus
    Азимова Макка Ризвановна, Yu. V. Zhernakova, Marina A. Saidova, Irina E. Chazova · 2022 · Systemic Hypertension
  29. Epicardial and pericoronary fat
    Pál Maurovich‐Horvat, György Jermendy · 2023 · Elsevier eBooks
  30. Obesity in relation to cardiorenal function
    Isabella Nguyen, Jaap A. Joles, Marianne Christina Verhaar, Hildo J. Lamb, Ilona A. Dekkers · 2023 · Elsevier eBooks
  31. Medical therapy
    Janina Senn, Stefan Fischli · 2023 · Elsevier eBooks
  32. The Silent Player
    Maryam Mojarrad Sani, Jonathan Chrispin · 2023 · JACC Case Reports
  33. Effect of Liraglutide on Weight Loss and BMI Among Patients Who Are Overweight and Obese with Type 2 Diabetes: A Systematic Review and Meta-analysis
    C. Zorampari, Rachna Gupta, Lalit K Gupta · 2023 · European Medical Journal
  34. Long-term effects of metformin on fat depots and insulin-glucose parameters in patients with prediabetes and chronic heart failure
    Цыганкова Оксана Васильевна, N. E. Apartseva, Lydmila D. Latyntseva, Andrew N. Ryabikov, Elena Vladimirovna Kashtanova · 2024 · Meditsinskiy sovet = Medical Council
  35. Molecular Pathways in Diabetic Cardiomyopathy and the Role of Anti-hyperglycemic Drugs Beyond Their Glucose Lowering Effect
    Jie-Eun Lee, Byung Gyu Kim, Jong Chul Won · 2025 · Journal of Lipid and Atherosclerosis
  36. Fluctuations of epicardial adipose tissue and cardiovascular health: A useful biomarker? A comprehensive review
    Bekzod Isomitdinov, Muslim Mustaev, Malikabonu Khayatova, Gentjan Jakaj, James R. Whiteford, Aung Oo · 2025 · Journal of Cardiovascular and Thoracic Research
  37. Cardiovascular Effects of GLP-1 Analogues
    Lucio Amoresano · 2025 · Springer eBooks
  38. The role of epicardial fat in the progression of cardiovascular disease in women
    Ruzzell C Flores, Erele Tzidon, Inna Rabinovich-Nikitin · 2025 · Current Opinion in Physiology
  39. Additional file 1 of Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: a systematic review and meta-analysis
    Veronika A. Myasoedova, Valentina Parisi, Donato Moschetta, Vincenza Valerio, Maddalena Conte, Ilaria Massaiu, Michele Bozzi, Fabrizio Celeste, Dario Leosco, Guido Iaccarino et al. · 2024 · Figshare
  40. Additional file 2 of Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: a systematic review and meta-analysis
    Veronika A. Myasoedova, Valentina Parisi, Donato Moschetta, Vincenza Valerio, Maddalena Conte, Ilaria Massaiu, Michele Bozzi, Fabrizio Celeste, Dario Leosco, Guido Iaccarino et al. · 2024 · Figshare
  41. Obesity promotes atrial fat deposition independent of myocardial infarction in Göttingen minipigs
    Johs Dannesboe, Caroline Eggert Eggertsen, Karina Poulsdóttir Debes, Mette Flethøj, Lisbeth H. Olsen, Jacob Eifer Møller, Jeppe Egedal Kirchhoff, T. Falk, Nienke Anna Maria van Rooij, Trine Pagh Ludvigsen et al. · 2026 · Heart Rhythm O2
  42. Etude des effets de la glycation sur les interactions protéine-ligand dans le cadre du diabète et de l’athérosclérose : la liaison entre l’albumine et le liraglutide et entre l’apolipoprotéine A1 et ses partenaires de liaison
    Angélique Galahi Soudahome · 2018 · theses.fr (ABES)
  43. The effect of apremilast on epicardial adipose tissue in psoriasis
    Joel M. Gelfand, Andrew Z. Li, William B. Song, Mohanad Ghonim, Abass Alavi, Ravi Ramessur, Robert C. Fitzsimmons, Michael Seth Garshick, Nehal N. Mehta, Gianluca Iacobellis et al. · 2026 · Journal of Investigative Dermatology
  44. Epicardial adipose tissue in cardiovascular diseases: a potential therapeutic target
    Zhaoting Gong, Yuyan Xiong · 2026 · Frontiers in Cardiovascular Medicine
  45. Association between body mass index reduction and epicardial adipose tissue changes across pharmacological and lifestyle interventions: a multilevel meta-regression analysis
    Aleksandra Mączyńska, Piotr Olbryś, Mateusz Smoliński, Miłosz Rosa, Marta Kacperska, Milena Froń, Paweł Leśniewski, Oliwia Łuniewska, Adam Sander, Maciej Mączewski et al. · 2026 · Cardiovascular Diabetology
  46. Epicardial Adipose Tissue in Diabetic Heart Disease: Impact on Cardiac Function and Modulation Strategies, a Comprehensive Review
    Ana Đuzel, Petra Grubić Rotkvić, Zdravko Babić, Ivana Huljev Šipoš, Marijo Bekić, Marina Njire Bratičević, Luka Rotkvić, Maja Cigrovski Berković · 2026 · Medicina
  47. Epicardial adipose tissue in obesity-related heart failure with preserved ejection fraction and atrial fibrillation: mechanisms, imaging, and therapeutic modulation
    Zhu Qi, Tiance Xu, Chen Yang, Lili Tan · 2026 · Frontiers in Endocrinology
  48. The Effects of GLP ‐ 1RA ‐Based and SGLT2 Inhibitor Therapy on Perirenal Adipose Tissue in CKD Patients
    Ana Checa-Ros, Oscar Arias‐Mutis, Owahabanun‐Joshua Okojie, Pilar Salvador, Luis D’Marco · 2026 · Diabetes Obesity and Metabolism
  49. From Adiposity to Diastolic Dysfunction: The Integrated Role of Epicardial Fat, Autonomic Dysregulation, and Morning Blood Pressure Surge in Obesity
    Ayhan Coşgun, Hüseyin Ören · 2026 · International Journal of Hypertension
  50. GLP-1 receptor agonist therapy and incident atrial fibrillation in non-diabetic adults with obesity and chronic kidney disease: a propensity matched cohort study
    Abdulraheem Hassan, Efeturi Okorigba, Chilaka Grace, Emmanuel Otabor, Busayo Samuel Osineye, Olalekan Paul Olayiwola, Tutuola Oyeleye, Parthiv Amin · 2026 · International Journal of Cardiology
  51. Epicardial Adipose Tissue as a Dynamic Modulator of Coronary Artery Disease Phenotypes: Pathophysiology and Therapeutic Implications
    Seyed Amirhossein Dormiani Tabatabaei, Mehrnazsadat Dormiani Tabatabaei · 2026 · Clinical Cardiology